Program Manual - Saint Louis University

h. Six week follow up: Appointment will be scheduled at Employee Health. After informed consent, HIV
testing will be performed. Employee Health will provide pre-test counseling. Results will be reported to
the HCW and post-test counseling will be provided. Appointment compliance is monitored by Employee
Health only if the source patient has known HIV infection.
i. Three month follow up: Appointment will be scheduled at Employee Health. After informed consent,
HIV testing will be performed. Employee Health will provide pre-test counseling. Results will be
reported to the HCW and post-test counseling will be provided. Appointment compliance is monitored
by Employee Health only if the source patient has known HIV infection.
j. Six month follow up: Appointment will be scheduled at Employee Health. After informed consent, HIV
testing will be performed. Employee Health will provide pre-test counseling. Results will be reported to
the HCW and post-test counseling will be provided. Appointment compliance is monitored by Employee
Health only if the source patient is known to have HIV infection.
k. 12 month follow up: Appointment will be scheduled at Employee Health. After informed consent, HIV
testing will be performed. Employee Health will provide pre-test counseling. Results will be reported to
the HCW and post-test counseling will be provided.
l. All HCW results are confidential
m. As required by law all positive HIV results will be reported to the Missouri Department of Health.
n. All evaluation, treatment, and testing are at no cost to the HCW or the source patient.
o. All exposed HCWs are counseled regarding reducing the transmission of HIV during the twelve months
of follow up. This includes:
1. Avoiding blood, semen, or organ donations.
2. Adopting safer sex practices.
3. Deferring pregnancy.
p. All exposed HCWs are advised of Employee Assistance Program services. These support services are
available at the request of the HCW.
q. Records of the exposure will be maintained in the Employee Health HCW files for duration of
employment plus 30 years.
2. Hepatitis B Virus
a. Risk assessment -- High risk source patients for Hepatitis B are patients with suspected acute hepatitis,
known chronic hepatitis, hematology-oncology patients, dialysis patients, hemophiliacs and patients with
other coagulopathy disorders, those who use illicit intravenous drugs, and other patients based on clinical
judgment.
b. Baseline testing for hepatitis B surface antigen screen will be obtained at the time of the post-exposure
evaluation. Quantitative antibody to hepatitis B surface antigen testing will be obtained if not previously
documented.
c. Evaluation of the source patient
1) Employee Health staff nurse will provide counseling regarding hepatitis B surface antigen screen
testing.
2) Hepatitis B surface antigen screen will be obtained.
3) Attending physician will be notified of pending lab results on the source patient.
4) Employee Health physician will evaluate the risk of the source patient by HCW’s history of the
source patient, review of available source patient history, and report from attending physician.
5) The physicians providing care for the source patient will be informed of any positive results from the
source patient laboratory tests.
6) Exposed HCW will be notified of the source patient results.
E-8